Global Psychedelic Therapeutics Market, 2020-2030

BOGART, Ga. - Oct. 6, 2020 - PRLog -- he report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:

§  A detailed assessment of the current market landscape of drug developers engaged in the development of psychedelic therapeutics.

§  Tabulated profiles of prominent psychedelic therapeutics developers. shortlisted on the basis of the number of pipeline products).

§  Detailed profiles of developers of next generation immune checkpoint modulators (shortlisted on the basis having two or more psychedelics-based therapies in phase II clinical studies and above).

§  An insightful analysis of clinical trial sites where the studies have been / are being conducted for evaluation of various psychedelic therapeutics.

§  A list of key opinion leaders (KOLs) within this domain, and detailed 2×2 matrices to assess the relative experience of key individuals who were shortlisted based on their contributions (in terms of involvement in various clinical studies) to this field.

§  A detailed analysis of nearly 545 grants that have been awarded to research institutes engaged in psychedelic therapeutics projects, in the period between 2015 and 2020 (till May).

§  An analysis of the partnerships that have been established in the recent past (2017-2020 till May),

§  A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2017-2020.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§  Target Disease Indication

§  Anxiety and Depression

§  Trauma

§  Pain Disorder

§  Sleep related Disorder

§  Origin of Psychedelic Substance

§  Natural

§  Synthetic

For additional details, please visit
https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html or email sales@rootsanalysis.com

You may also be interested in the following titles:

1.      Endocannabinoid System Targeted Therapeutics Market, 2020-2030 (https://www.rootsanalysis.com/reports/view_document/endoc...)

2.      Depressive Disorders (Major Depression, Bipolar Disorder, Postpartum Depression, (https://www.rootsanalysis.com/reports/view_document/depressive-disorders-major-depression-bipolar-disorder-postpartum-depr/252.html) Treatment-Resistant Depression and Others): Pipeline Review, Developer Landscape and Competitive Insights, 2019

3.      Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights

4.      Neoantigen Targeted Therapies Market, 2019-2030

5.      Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com